Pharmaceuticals & Biotechnology

Mankind Pharma Limited

ISIN: INE634S01028 · Data as of Oct 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
104
vs Last Month
-8 funds
Total Value
₹9,943.16 Cr
Avg Weight
12.78%
New Entries
7
Exits
15
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #119
₹59.52 K Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
→
₹91.89 K Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+54.4%
3yr change
Large Cap → Mid Cap in 3 years
SEBI · AMFI Market Cap List
📋 What Changed This Month Mankind Pharma Limited is currently held by 104 active mutual funds with total exposure of ₹9,943.16 Cr. This month 7 funds entered and 15 funds exited. Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option has the highest allocation at 440%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 5 Months?

Month Funds AUM (Cr) AMCs Status
Oct 2026 REFERENCE 104 ₹9,943 48 / 49
Sep 2026 112 ₹11,115 49 / 49 ✅ Complete
Aug 2026 108 ₹10,184 49 / 49 ✅ Complete
Jul 2026 114 ₹10,477 49 / 49 ✅ Complete
Jun 2026 116 ₹10,946 49 / 49 ✅ Complete

📌 Portfolio changes below are based on Oct 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Oct 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 31 16.06%
Mid Cap 22 10.52%
Large Cap 10 12.17%
ELSS 7 23.71%
Balanced Advantage 7 7.68%
Multi Cap 7 0.91%
Flexi Cap 6 32.99%
Multi Asset 6 6.44%
Aggressive Hybrid 3 1.08%
Focused 2 3.79%
Value/Contra 2 1.63%
Small Cap 1 1.11%
All Holdings

Which 104 Active Funds Hold Mankind Pharma Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 440% ₹399.74 Cr +435.62%
Nippon India Growth Mid Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Mid Cap 199% ₹972.19 Cr +197.05%
Nippon India Flexi Cap Fund - Direct Plan - Growth Plan - Growth Option
Nippon India Mutual Fund
Flexi Cap 191% ₹171.60 Cr +189.13%
Nippon India ELSS Tax Saver Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
ELSS 160% ₹223.25 Cr +158.41%
Nippon India Large Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Large Cap 108% ₹563.86 Cr +106.96%
Nippon India Balanced Advantage Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Balanced Advantage 50% ₹47.36 Cr +49.5%
Nippon India Multi Asset Allocation Fund - Direct Plan - Growth Option
Nippon India Mutual Fund
Multi Asset 35% ₹63.70 Cr +34.65%
ICICI Prudential Healthcare Fund
ICICI Prudential Mutual Fund
Equity 4.5% ₹319.41 Cr -0.54%
Edelweiss Focused Fund - Direct Plan - Growth
Edelweiss Mutual Fund
Focused 4.47% ₹41.83 Cr +0.09%
PGIM India Healthcare Fund - Direct Plan - Growth Option
PGIM India Mutual Fund
Equity 3.95% ₹5.61 Cr -0.09%
Motilal Oswal Innovation Opportunities Fund - Direct Plan- Growth
Motilal Oswal Mutual Fund
Equity 3.88% ₹32.62 Cr NEW
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund
Equity 3.75% ₹10.01 Cr -0.03%
Franklin India Opportunities Fund - Direct - Growth
Franklin Templeton Mutual Fund
Equity 3.66% ₹335.53 Cr -0.32%
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND
Aditya Birla Sun Life Mutual Fund
Equity 3.56% ₹38.78 Cr -0.06%
Tata Mid Cap Fund - Direct Plan- Growth Option
Tata Mutual Fund
Mid Cap 3.49% ₹199.42 Cr +0.07%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.